Treatment of tissues to reduce subsequent response to injury

• US 6,071,956 A
• Filed: 09/23/1998
• Issued: 06/06/2000
• Est. Priority Date: 10/11/1994
• Status: Expired due to Term

• Current Assignee: Endoluminal Therapeutics Incorporated
• Original Assignee: Endoluminal Therapeutics Incorporated
• Inventors: Massia, Stephen P., Slepian, Marvin J.
• Primary Examiner(s): Dodson, Shelley A.
• Assistant Examiner(s): Williamson, Michael A.
• Application Number:
  US09/158,725
• Time in Patent Office: 622 Days
• Field of Search: 514/496, 604/101, 604/102, 604/103, 604/95, 604/96, 604/97, 604/98, 604/99, 606/191, 606/194, 606/195
• US Class Current: 514/496
• CPC Class Codes: A61K 41/0023 Agression treatment or altering
• CPC Class Codes: A61P 39/00 General protective or antinoxious agents
• CPC Class Codes: A61P 43/00 Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
• CPC Class Codes: A61P 7/02 Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Abstract

An exogenous stimulus is applied to tissues or cells which are at risk in a subsequent surgical procedure or other intervention which induces a response by the cells that minimizes reaction to the subsequent procedure. Stimuli can be chemical, physiological or physical. Examples include those stimuli known to induce expression of stress response proteins or heat shock proteins, especially heat shock protein 70 (hsp 70) and hsp 90, for example, exposure to heat or dilute hydrogen peroxide, or direct administration of exogenous heat shock proteins, or those stimuli which act to inhibit or reduce heat shock protein expression, for example, treatment with flavonoids. An amount effective to modulate levels of stress response proteins or reduce the endogenous response is administered, based on in vitro assays which are used to determine levels of heat shock proteins or which are experimentally determined to reduce cell proliferation, thrombus formation, and matrix deposition following subsequent exposure to a procedure. Procedures can be surgery, angioplasty, or abrasion. The method and compositions are also useful in mediating some disease processes, where the process involves undesirable migration.

Claims

1. A composition for altering subsequent cellular responses to a therapeutic intervention at a tissue locus in vivo, the composition comprising a reagent or a material inducing a change in a physical condition, in a physiologically acceptable carrier or manner, in an amount effective to induce altered levels of heat shock proteins or stress response proteins in cells to be treated and thereby alter proliferation or migration of cells which would otherwise occur in response to a therapeutic intervention.

3. The method of claim 1 further comprising mixing the stimulus with an immobilizing system.

4. The composition of claim 1 wherein the reagent or physical condition is a physical stimulus selected from the group consisting of heat, cold, ultrasound, light, vibration, and pressure in an amount effective to induce expression of stress response proteins or heat shock proteins without killing the cells to be treated.

5. The composition of claim 1 wherein the reagent or physical condition is a physiological stimulus selected from the group consisting of glucose deprivation and oxygen deprivation.

6. The composition of claim 1 wherein the reagent or physical condition is a chemical stimulus selected from the group consisting of oxidants and heavy metals in an amount effective to induce expression of stress response proteins or heat shock proteins without killing the cells to be treated.

7. The composition of claim 1 wherein the reagent or physical condition is a flavonoid in an amount effective to reduce expression of heat shock proteins without killing the cells to be treated.

8. The composition of claim 1 wherein the treated cells exhibit decreased proliferation as compared with untreated cells following exposure to trauma.

9. The composition of claim 1 wherein the treated cells exhibit decreased migration as compared with untreated cells following exposure to the stimulus.

10. The composition of claim 1 further comprising a polymeric material.

11. The composition of claim 10 wherein the polymeric material is selected from the group consisting of hydrogels, organogels, polymeric films, and microparticles.

12. The composition of claim 1 wherein the reagent or physical condition is a purified stress response protein or heat shock protein.

13. The composition of claim 12 wherein the reagent or physical condition is a heat shock protein.

2. A method of making a composition suitable for altering subsequent cellular responses to a therapeutic intervention at a tissue locus in vivo, comprising mixing an agent known to act as an inducing stimulus on the targeted cells as determined by altered expression of heat shock proteins or stress response proteins, with a pharmaceutically acceptable carrier.